SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: CuttingEdge Bio who wrote (3240)2/10/2021 12:16:41 AM
From: Biotechwantabe  Read Replies (2) | Respond to of 3557
 
Well regeneron will get plenty of opportunity in row starting with Evkeeza. We always blame the partners but it’s regeneron that responsible for making a bad deal.
Hopefully they hire some good global sales execs.
Libtayo cemo will be the big test.
Too bad Roche can’t buy out sanofi



To: CuttingEdge Bio who wrote (3240)2/11/2021 1:18:12 AM
From: Miljenko Zuanic2 Recommendations

Recommended By
CuttingEdge Bio
The Ox

  Respond to of 3557
 
< I am starting to really hate this company>
You are only +10 years late!